Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1441 to 1455 of 1467 results for pathway

  1. NICE collaboration on streamlined licensing and patient access process for new medicines opened on January 1st

    Companies can now submit medicines for the new Innovative Licensing and Access Pathway (ILAP) following close collaboration between the NICE, drug regulators, the NHS and equivalent organisations in Scotland.

  2. Minimum pricing for alcohol 'will protect young people'

    Setting a minimum price per unit of alcohol, as recommended by NICE, will protect young people from the dangers of excessive drinking, according to a new report.

  3. Free BNF for children app launches

    Health and social care professionals can now download for free the NICE British National Formulary for children (BNFC) app available for smart phones and tablets.

  4. Fertility treatments should be 'appropriate, effective and timely' says NICE

    GPs should offer appropriate and effective fertility treatments in a timely manner for women having problems with conception, according to latest guidelines from NICE.

  5. Age 'should not be barrier to treatment'

    Decisions around whether to offer a person surgical treatment should not be based on age and fitness, according to a new report.

  6. Appeal panel rules that NICE needs to request evidence for erenumab effectiveness in subgroup of people with chronic migraine

    NICE has today (4 February 2020) published the outcome of the appeal against its final draft guidance (FAD) on erenumab (also called Aimovig and made by Novartis) for preventing chronic migraine.

  7. Commissioning services for people with hip fracture

    NICE has produced a guide for commissioners on hip fracture services, which provides advice on commissioning services for people with fragility fracture of the hip or fracture of the hip due to osteoporosis or osteopenia.

  8. NICE recommends elosulfase alfa for routine NHS use for patients with rare life-limiting metabolic disorder

    People with a rare condition that steadily worsens often leaving them dependent on a wheelchair and with shortened life expectancy, can now benefit from the first treatment to slow its progression.

  9. NICE publishes updated clinical guideline on the diagnosis and management of atrial fibrillation

    NICE has today (27 April 2021) published its updated guideline on the diagnosis and management of atrial fibrillation (AF).

  10. NICE unveils safe staffing plans for nursing care in wards

    NICE has published new guidance setting out ‘red flag events’ which warn when nurses in charge of shifts must act immediately to ensure they have enough staff to meet the needs of patients on that ward.

  11. Novel oral anticoagulants an option for patients with atrial fibrillation

    Offering patients anticoagulants could help prevent thousands of strokes and premature deaths from atrial fibrillation (AF), according to NICE.

  12. Offer less invasive treatments before surgery for varicose veins

    Surgery should only be offered to treat varicose veins if other less invasive treatments are unsuitable for patients, according to latest guidance from NICE.

  13. In the bag - making moving between hospital and social care better

    The introduction of a 'red bag' Hospital Transfer Pathway has helped to improve and speed up the transfer between hospital and care home settings.

  14. Prompt diagnosis of social anxiety disorder leads to effective treatment

    A prompt diagnosis of social anxiety disorder is crucial in ensuring people access the most clinical and cost effective treatment, according to NICE.

  15. Ovarian cancer patients to have NICE-approved drug combination option on Cancer Drugs Fund

    A potentially life-extending drug combination for some people with advanced, high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer will now be available on the Cancer Drugs Fund (CDF), following its approval by NICE in draft guidance published today.